“…However, despite the promising outcomes in several fields, systematic literature reviews demonstrated that, despite the adequate bone formation achieved by utilization of recombinant human bone morphogenetic protein 2 (rhBMP-2; INFUSE Bone Graft; Medtronic Sofamor Danek, Memphis, TN, USA), further research is needed (Guo et al, 2011;Van Hout et al, 2011). The greater facial edema without need of analgesic and antiinflammatory therapy was cited as a possible side effect associated with rhBMP-2 (Herford et al, 2007;Alonso et al, 2010;Carvalho, 2011;Leal et al, 2015), which indicates this protein as a viable alternative material for that purpose.…”